Comparative flow cytometric evaluation of bcl-2 oncoprotein in CD5+ and CD5- B-cell lymphoid chronic leukemias

Haematologica

Volumn 82, Issue 5, 1997, Pages 555-559

  Molica, Stefano ^a,b   Mannella, Ada ^a   Crispino, Giulino ^a   Dattilo, Angela ^a   Levato, Domenico ^a  

^a PUGLIESE CIACCIO HOSPITAL   (Italy)

^b Azienda Ospedaliera   (Italy)

Author keywords

Apoptosis; B CLL; Bcl 2; Flow cytometry

Indexed keywords

CD5 ANTIGEN; ONCOPROTEIN; PROTEIN BCL 2;

ADULT; APOPTOSIS; ARTICLE; B CELL LEUKEMIA; CHRONIC LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MALE; PROTEIN EXPRESSION;

AGED; ANTIGENS, CD5; B-LYMPHOCYTES; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; LEUKEMIA, B-CELL, CHRONIC; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; REAGENT KITS, DIAGNOSTIC;

EID: 0031466593     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Gaidano G, Pastore C, Volpe G. Molecular pathogenesis of non-Hodgkin lymphoma. A clinical perspective. Haematologica 1995; 80:454-72.
2. Hanada M, Delia D, Aiello A, Stadtmauer E, Reed JC. Bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 1993; 80:768-75.
3. Robertson LE, Plunkett W, McConnell K, Keating MJ, McDonnell TJ. Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome. Leukemia 1996; 10:456-9.
4. Caligaris-Cappio F. B-chronic lymphocytic leukemia: a malignancy of anti-self B cells. Blood 1996; 87:2615-20.
5. Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992; 80:879-86.
6. Gottardi D, Alfarano A, De Leo AM, et al. In leukemic CD5+ B cells the expression of bcl-2 gene family is shifted toward protection from apoptosis. Br J Haematol 1996; 94:612-8.
7. Pepper C, Bentley P, Hoy T. Regulation of clinical chemoresistance by bcl-2 and bax oncoproteins in B-cell chronic lymphocytic leukemia. Br J Haematol 1996; 95:513-7.
8. Molica S, Mannella A, Dattilo A, et al. Differential expression of bcl-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis. Haematologica 1996; 81:302-9.
9. Geisler CH, Larsen JK, Nansen NE, et al. Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood 1991; 78:1795-802.
10. Kurek AS, Threatte GA, Gottlieb AJ, Smith JR, Anderson J, Davey FR. Immunophenotypic subclassification of chronic lymphocytic leukemia. Br J Haematol 1992; 81:45-51.
11. Salomon-Nguyen F, Valensi F, Merle-Beral H, Flandrin G. A scoring system for the classification of CD5- B-CLL versus CD5+ B-CLL and B-PLL Leuk Lymphoma 1995; 16:445-50.
12. International Workshop on CLL. Recommendations for diagnosis, staging, and response criteria. Ann Intern Med 1989; 110:236-8.
13. Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981; 48:198-206.
14. Rozman C, Montserrat E, Rodriguez-Fernandez JM, et al. Bone marrow histologic pattern. The best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis. Blood 1984; 64:642-8.
15. Molica S, Alberti A. Prognostic value of the lymphocyte doubling time in chronic lymphocytic leukemia. Cancer 1987; 60:2712-6.
16. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of chronic (mature) B and T lymphoid leukemias. J.Clin. Pathol. 1989; 42:567-84.
17. Pizzolo G, Vincenzi C, Nadali G, et al. Detection of membrane and intracellular antigens by flow cytometry following ORTHO permeafix fixation. Leukemia 1994; 8:672-8.
18. Matures E, Owusu-Ankomah K, Morilla R, et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL Leukemia 1994; 8:1640-5.
19. Mapara MY, Bargon R, Zugok C, et al. APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression. Eur J Immunol 1993; 23:702-8.
20. Panayiotidis P, Ganeshaguru K, Foroni L, Hoffbrand AV. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia. Leukemia 1995; 9:1227-32.
21. Montserrat E. Chronic lymphoproliferative disorders. Curr Opin Oncol 1997; 9:34-41.
22. Coustan-Smith E, Kitanada A, Pui CH. Clinical relevance of bcl-2 overexpression in childood acute lymphoblastic leukemia. Blood 1996; 87:1140-6.
23. Del Poeta G, Venditti A, Aronica G, et al. High proliferative rate detected by transferrin receptor is associated both with low intensity of bcl-2 expression and poor outcome in acute myeloid leukemia. Blood 1996; 88(suppl 1):85a.
24. Thomas A, El Roubry S, Reed S. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p-53 gene mutation and bcl2/bax proteins in drug resistance. Oncogene 1996; 12:1055-62.
25. Molica S, De Rossi G, Luciani M, Levato D. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update. Haematologica 1995; 80:176-93.
26. Morabito F, Filangeri M, Callea I, et al. Bcl-2 protein expression and p53 mutation in chronic lymphocytic leukemia: correlation with in vitro sensivity to chlorambucil and purine analogs. Haematologica 1997; 82:16-20.
27. Mentz F, Blanc C, Michel A, Binet JL, Merle-Beral H. Expression of bcl-2, p53, and c-myc proteins in chronic lymphocytic leukemia: correlation with apoptosis. Blood 1994; 84(suppl 1):657a.
28. Yang E, Korsmeyer SJ. Molecular thanatopsis: a discourse on the bcl-2 family and cell death. Blood 1996; 88:386-401.